Merle buys GILD 82.18: Biotechnology Equities Technical Notes -- Research on StemCells, Gilead Sciences, Galena Biopharma, and Inovio Pharma
On Wednesday, June 25, 2014, the NASDAQ Composite ended at 4,379.76 ... StemCells Inc. STEM, Gilead Sciences Inc. GILD, Galena Biopharma Inc. GALE and Inovio Pharmaceuticals Inc (NYSE MKT: INO). Free technical research on STEM, GILD, GALE and INO can ... ...
53 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home